Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05073692 · ClinicalTrials.gov registry record
Comparison of Type 2 Diabetes Pharmacotherapy Regimens
A clinical trial, sponsored by Kaiser Permanente.
- Completed
- Registry status
- 241,981
- Enrollment target
NCT05073692 is a clinical trial that has completed, run by Kaiser Permanente. The registered enrollment target is 241,981 participants.
The verdict
NCT05073692 has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- 241,981 participants
- Enrollment target
Study Summary
This study is designed to help patients with type 2 diabetes and their clinicians: (a) identify which glucose lowering medications have the most favorable effects on heart health and other patient-important outcomes, (b) inform the timing of medication initiation, and (c) identify whether medication benefits apply equally to all adults with type 2 diabetes, or may be different based on age, sex, race/ethnicity, baseline heart health status, baseline renal function, or other factors.
Interventions
- DRUG GLP-1RA
- DRUG SGLT2i
- DRUG SU
- DRUG DPP4
- DRUG SGLT2i or GLP-1RA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 241,981 participants |
| Start Date | 2021-07-01 |
| Est. Completion | 2025-03-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05073692
The ClinicalTrials.gov registry entry for NCT05073692 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 241,981 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which GLP-1RA is the first listed.
NCT05073692 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05073692 about?
NCT05073692 is a clinical study titled "Comparison of Type 2 Diabetes Pharmacotherapy Regimens". This study is designed to help patients with type 2 diabetes and their clinicians: (a) identify which glucose lowering medications have the most favorable effects on heart health and other patient-important outcomes, (b) inform the timing of medication initiation, and (c) identify whether medication...
What is the current status of trial NCT05073692?
This trial is currently completed. The enrollment target is 241,981 participants. The study started on 2021-07-01. Estimated completion is 2025-03-12.
What interventions are being tested in trial NCT05073692?
The interventions under investigation include: GLP-1RA (DRUG), SGLT2i (DRUG), SU (DRUG), DPP4 (DRUG), SGLT2i or GLP-1RA (DRUG).
Who is sponsoring clinical trial NCT05073692?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.